Evercore ISI analyst Cory Kasimov downgraded Arcellx (ACLX) to In Line from Outperform with a $115 price target following the announcement that Gilead (GILD) is acquiring the company for $115 per share upfront plus a $5 contingent value right in what the firm calls “the ending most wanted.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACLX: